true
{"AlternateComparison":false,"RelatedProducts":false,"Specification":true,"FeatureBenefit":false}
BD Onclarity™ Molecular biology reagents BD Onclarity™ HPV Assay

BD HPV CONTROL SET

Icon to close the modal
Support
Customer Care & Ordering
Phone Icon
866 979 9408, (905 288 6000 non toll free)
Modal Close Icon
Contact Us
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Overview

The BD Onclarity™ HPV Assay is FDA and Health Canada approved for extended genotyping, offering the flexibility you need to adapt to changing screening guidelines and evolving patient management guidance.

FDA and Health Canada approved for all three screening paradigms:

In the post-vaccination era the prevalence of high-risk genotypes may change making it crucial to identify high-risk genotypes individually.

  • Extended genotyping supports risk stratification and persistence monitoring to guide patient management1-5
  • Genotypes 16 and 18 account for 70% of invasive cancer worldwide, but their prevalence is declining as vaccination rates increase.6-9
  • Genotypes 31,33,58 have a CIN3+ risk similar to genotype 18, but 51,35,39,68,56,59,66 have a much lower risk.10-11
true
Features and Benefits
Promotional Story
false
Specification

GTIN - each

00382904440886

1


Quantity - Each

1


Shelf Life (Days)

528

GTIN

GTIN - each 00382904440886 1

Packaging

Quantity - Each 1

Storage and Handling

Shelf Life (Days) 528
Electronic Instructions for Use (eIFUs)
Resources
Frequently Asked Questions
false
Related Products
RELATED PRODUCTS NOT AVAILABLE
Product Complaints
North American Regional Complaint Center
1-844-8BD-LIFE (1-844-823-5433)
Things to Consider

If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.

To better facilitate our investigation, please include the following information in your reporting:


  • Product Name and/or Catalog Number
  • Lot Number or Serial Number
  • Any injuries and/or Harm?
  • What is the issue you experienced?
  • Is the actual sample or sample representative available? (If possible, please send affected sample)
  • Contact name and phone number
References
false
true